Drugs / COLESTILAN CHLORIDE
COLESTILAN CHLORIDE
also known as
MCI-196 · Colestilan · CHOLEBINE · Colestimide · Bindren · Cholebine (japan) · colestilan(INN) · Colestimide(JAN)
Regulatory milestones approvals, filings & regulatory actions · 2 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Withdrawn | EU (EMA) | BindRen | — | 2015-05-26 | europa.eu ↗ |
| Approved | EU (EMA) | BindRen | — | 2013-01-21 | europa.eu ↗ |
Trials 11 · a red edge is where a trial was stopped
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT01976572 Comparator | Oct 2013 → Jan 2014 | chronic kidney disease, hyperphosphatemia | Tanabe Pharma Corporation | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT00548145 Comparator | Nov 2007 → Oct 2011 | Alzheimer disease, hyperlipidemia | Osaka University | Terminated | No outcome recorded |
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 15 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | COLESTILAN CHLORIDE | ChEMBL registry synonym — accepted as the source's own label CHEMBL2103800 ↗ |
| Known as | Bindren | ChEMBL registry synonym — accepted as the source's own label CHEMBL2103800 ↗ |
| Known as | CHOLEBINE | “MCI-196 (Colestilan(INN), Colestimide(JAN), CHOLEBINE®)” NCT00416520 ↗1“MCI-196(colestilan(INN), Colestimide(JAN), CHOLEBINE®)” NCT00451295 ↗ |
| Known as | Cholebine (japan) | ChEMBL registry synonym — accepted as the source's own label CHEMBL2103800 ↗ |
| Known as | Colestilan | “MCI-196 (Colestilan(INN), Colestimide(JAN), CHOLEBINE®)” NCT00416520 ↗ |
| Known as | colestilan(INN) | “MCI-196(colestilan(INN), Colestimide(JAN), CHOLEBINE®)” NCT00451295 ↗ |
| Known as | Colestimide | “MCI-196 (Colestilan(INN), Colestimide(JAN), CHOLEBINE®)” NCT00416520 ↗ |
| Known as | Colestimide(JAN) | “MCI-196(colestilan(INN), Colestimide(JAN), CHOLEBINE®)” NCT00451295 ↗ |
| Known as | MCI-196 | “The objective of this study is to assess the safety and tolerability of colestilan (MCI-196) in paediatric subjects (aged 2 years to \<18 years) with CKD stages 3b to 5,...” NCT01818687 ↗9“treatment with colestilan (MCI-196)” NCT01814917 ↗ |
| Modality | Other / unclassified | “a bile acid sequestrant” PMID 20047620 ↗ Sep 2009 |
| Route | Oral | “Colestilan was administered orally 5 g t.i.d” NCT01976572 ↗ |